Comparative Analysis of the Efficacy and Safety of PreserFlo MicroShunt and Trabeculectomy in Glaucoma Management: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Outcomes and Influencing Factors - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Comparative Analysis of the Efficacy and Safety of PreserFlo MicroShunt and Trabeculectomy in Glaucoma Management: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Outcomes and Influencing Factors
Clinical Scorecard: Comparative Analysis of the Efficacy and Safety of PreserFlo MicroShunt and Trabeculectomy in Glaucoma Management: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Outcomes and Influencing Factors
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Care Setting
Ophthalmology clinics, surgical centers, and inpatient facilities
Key Highlights
Add specific data or statistics on efficacy and safety outcomes.
Guideline-Based Recommendations
Diagnosis
Management
Consider PreserFlo MicroShunt for patients with contraindications to trabeculectomy, including specific contraindications.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
PreserFlo MicroShunt may reduce the need for antiglaucoma medications compared to trabeculectomy, supported by specific studies.
Clinical Best Practices
Utilize a standardized protocol for patient selection and surgical technique, detailing specific criteria.
Analysis of more than 61,000 patients found higher odds of elevated loneliness scores among those reporting blindness and those with diabetic retinopathy, but not among patients with glaucoma or age-related macular degeneration.
